Table 3. Genes up-regulated by 5-dAzaC treatment, TSA treatment, and BRG1 re-expression.
Differentially expressed genes were identified, as described in Material and Methods. Of the 86 genes up-regulated in 5-dAzaC treatment vs. DMSO, TSA treatment vs. DMSO, and BRG1-GFP re-expression vs. GFP, the 55 genes that increased more than two fold after BRG1 re-expression are shown.
| ANKRD6 | GFOD1 | GLIPR2 | NDRG1 | RAB31 |
| ANXA2 | GFPT2 | ID3 | NGEF | RASSF2 |
| ATF3 | DDX58 | ID4 | NMNAT2 | RHOU |
| BCL6 | EGR2 | KIF5C | OCC-1 | RIPK4 |
| BIK | EMILIN2 | KRT18P34 | ODC1 | S100A2 |
| C16orf45 | FAM89A | LAMB3 | PAQR9 | SLC30A3 |
| C6orf114 | FEZ1 | LGALS3 | PEA15 | SMAD3 |
| CCK | FTL | LMCD1 | PLCE1 | SRXN1 |
| CD83 | FYN | LOC26010 | PODXL | SULF2 |
| CGNL1 | GABARAPL1 | MEG3 | PPP1R14C | TPM1 |
| CHST2 | GADD45A | MTM1 | RAB11FIP5 | WWC3 |